Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection

por Jenny Clarke, Murielle Baltazar, Mansoor Alsahag, Stavros Panagiotou, Marion Pouget, William A. Paxton, Georgios Pollakis, Dean Everett, Neil French, Aras Kadioglu
Publicado 2021

Author Correction: Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity

por Stavros Panagiotou, Chrispin Chaguza, Reham Yahya, Teerawit Audshasai, Murielle Baltazar, Lorenzo Ressel, Shadia Khandaker, Mansoor Alsahag, Tim J. Mitchell, Marc Prudhomme, Aras Kadioglu, Marie Yang
Publicado 2021

Increased pathogenicity of pneumococcal serotype 1 is driven by rapid autolysis and release of pneumolysin

por Laura C. Jacques, Stavros Panagiotou, Murielle Baltazar, Madikay Senghore, Shadia Khandaker, Rong Xu, Laura Bricio-Moreno, Marie Yang, Christopher G. Dowson, Dean B. Everett, Daniel R. Neill, Aras Kadioglu
Publicado 2020